Navigate licensing, billing compliance, payor contracts, and census stability before closing on a behavioral health acquisition in the lower middle market.
Find Addiction Treatment Center Acquisition TargetsAcquiring an addiction treatment center requires scrutiny far beyond standard financial review. Buyers must evaluate state licensing status, accreditation standing, billing compliance history, payor mix concentration, and clinical staff credentials. With EBITDA multiples ranging 4–7x and significant regulatory exposure, thorough due diligence protects against post-close liability and census disruption.
Confirm the facility holds all required state and federal authorizations with no pending sanctions, lapses, or investigations that could threaten operational continuity post-close.
Obtain copies of all active state behavioral health and substance abuse treatment licenses. Confirm renewal dates, any prior lapses, corrective action plans, or pending complaints with the licensing authority.
Verify current accreditation certificates, last survey dates, and any cited deficiencies. Active accreditation is a key buyer criterion and signals billing eligibility with many commercial payors.
Confirm provider enrollment numbers, check OIG exclusion lists for all clinical staff, and review any RAC audit history or repayment demands that may represent undisclosed liabilities.
Assess revenue quality, payor diversification, reimbursement sustainability, and billing compliance to underwrite true normalized EBITDA and identify concentration or audit risk.
Break down revenue by payor type across 36 months. Flag facilities where a single payor exceeds 40% of revenue. Confirm commercial insurance represents at least 30% of collections.
Review coding practices, claims denial rates, and any self-disclosure or repayment history. Engage a healthcare billing specialist to sample 12 months of claims for upcoding or documentation gaps.
Catalog all active payor contracts, reimbursement rates, and credentialing status for clinical staff. Identify contracts requiring payor consent to assign upon ownership transfer.
Evaluate census stability, outcomes data, staff credentials, and key-person dependency to assess operational continuity and post-acquisition risk to patient volume.
Analyze monthly census, average length of stay, bed utilization, and discharge data for 36 months. Identify seasonal volatility, no-show rates, and early discharge patterns affecting revenue predictability.
Verify licensure for all counselors, MAT prescribers, and clinical directors. Review 24-month turnover data. High counselor churn elevates cost and signals culture or compensation issues.
Assess whether the founder holds primary referral relationships or clinical oversight roles. Confirm a second-tier leadership team exists and is contractually committed to stay post-close.
Lower middle market addiction treatment centers typically trade at 4–7x EBITDA. Accredited facilities with diversified commercial payor mix and stable census command the higher end of that range.
Yes. Addiction treatment centers are SBA-eligible businesses. Buyers typically finance 80–90% of the purchase price through SBA 7(a) loans with a seller note or equity injection covering the remainder.
Billing fraud exposure is the most significant risk. Pre-close claims audits, RAC audit history review, and escrow holdbacks for pre-closing liabilities are essential protections for buyers.
Review 36 months of census trends, analyze referral source concentration, and confirm key clinical staff are retained post-close. Earnouts tied to census targets help bridge valuation gaps tied to volume uncertainty.
More Addiction Treatment Center Guides
DealFlow OS surfaces targets with seller signals and motivation scores — so you know before you start diligence. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers